| Total (n=292,868) | Reference (n=114,160) | Pre-lockdown (n=117,603) | Lockdown (n=61,105) | |
|---|---|---|---|---|
| Beta blockers | 39,518 (13.5) | 13,981 (12.2) | 17,988 (15.3) | 7,549 (12.4) |
| ACE inhibitors | 12,995 (4.4) | 5,449 (4.8) | 5,195 (4.4) | 2,351 (3.8) |
| ARBs | 45,354 (15.5) | 17,742 (15.5) | 18,429 (15.7) | 9,183 (15.0) |
| MRA | 5,386 (1.8) | 1,985 (1.7) | 2,114 (1.8) | 1,287 (2.1) |
| DHP CCBs | 44,447 (15.2) | 17,836 (15.6) | 18,131 (15.4) | 8,480 (13.9) |
| Non-DHP CCBs | 2,584 (0.9) | 1,046 (0.9) | 787 (0.7) | 751 (1.2) |
| Diuretics | 12,995 (4.4) | 4,826 (4.2) | 5,415 (4.6) | 2,754 (4.5) |
| Nitrates | 4,091 (1.4) | 1,535 (1.3) | 1,585 (1.3) | 971 (1.6) |
| Ivabradine | 5,419 (1.9) | 2,168 (1.9) | 2,026 (1.7) | 1,225 (2.0) |
| SGLT2 inhibitors | 530 (0.2) | 162 (0.1) | 258 (0.2) | 110 (0.2) |
| P2Y12 receptor antagonists | 10,803 (3.7) | 3,955 (3.5) | 3,527 (3.0) | 3,321 (5.4) |
| Aspirin | 7,254 (2.5) | 2,882 (2.5) | 2,827 (2.4) | 1,545 (2.5) |
| DOACs | 2,278 (0.8) | 903 (0.8) | 831 (0.7) | 544 (0.9) |
| VKAs | 4,717 (1.6) | 1,683 (1.5) | 1,928 (1.6) | 1,106 (1.8) |
| Statins | 63,115 (21.6) | 24,835 (21.8) | 24,961 (21.2) | 13,319 (21.8) |
| Ezetimibe | 831 (0.3) | 397 (0.3) | 339 (0.3) | 95 (0.2) |
| Fibrates | 2,563 (0.9) | 905 (0.8) | 1,103 (0.9) | 555 (0.9) |
| Nicorandil | 1,867 (0.6) | 1,424 (1.2) | 442 (0.4) | 1 (0.0) |
| Trimetazidine | 1,320 (0.5) | 833 (0.7) | 175 (0.1) | 312 (0.5) |
| Methyldopa | 762 (0.3) | 326 (0.3) | 275 (0.2) | 161 (0.3) |
| Digitalis | 264 (0.1) | 99 (0.1) | 122 (0.1) | 43 (0.1) |